Sam-A-Pharm Co (XKRX:009300) ROCE % : 2.82% (As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Sam-A-Pharm Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sam-A-Pharm Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 2.82%.

Sam-A-Pharm Co ROCE % Historical Data

The historical data trend for Sam-A-Pharm Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sam-A-Pharm Co ROCE % Chart

Sam-A-Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

7.75

1.02

3.15

10.37

14.65

Sam-A-Pharm Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															8.48	19.13	21.60	13.89	2.82

Sam-A-Pharm Co ROCE % Calculation

Sam-A-Pharm Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	28695.325	/	( ( (203197.944 - 21558.146)	+	(231307.913 - 21144.569) )	/ 2 )
	=	28695.325	/	( (181639.798	+	210163.344)	/ 2 )
	=	28695.325	/	195901.571
	=	14.65 %

Sam-A-Pharm Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	6245.664	/	( ( (245957.738 - 24531.657)	+	(245137.082 - 23111.063) )	/ 2 )
	=	6245.664	/	( ( 221426.081	+	222026.019 )	/ 2 )
	=	6245.664	/	221726.05
	=	2.82 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Sam-A-Pharm Co (XKRX:009300) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sam-A-Pharm Co ROCE % Related Terms

Thank you for viewing the detailed overview of Sam-A-Pharm Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sam-A-Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sam-A-Pharm Co Ltd (XKRX:009300) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

265 Ojeon-Dong, Uiwang-Si, KOR, 437-832

Website

http://www.samapharm.co.kr

Sam-A-Pharm Co Ltd is a South Korea based company engages in the manufacturing of pharmaceutical products. Its products include medicines for cold and fever, inflammatory, allergy, nutrition, and respiratory and digestive systems.

Sam-A-Pharm Co Headlines

No Headlines